CMC Reviewer Expectations for ANDAs Using QbD Approaches | AIChE

CMC Reviewer Expectations for ANDAs Using QbD Approaches

Type

Conference Presentation

Conference Type

AIChE Annual Meeting

Presentation Date

October 18, 2011

Duration

30 minutes

Skill Level

Intermediate

PDHs

0.50

There has been an increase in science and risk-based approaches under the Quality by Design paradigm in new drug submissions to the FDA. There are particular challenges for generic drug manufacturers with respect to using QbD approaches, especially with more complex dosage forms, such as modified release (MR) products. In an effort to increase transparency with the generic industry and the pharmaceutical industry at large, this presentation will provide insight into CMC reviewer expectations when evaluating pharmaceutical development studies, the applicant’s process and product understanding, use of risk assessment tools, and proposed control strategies.

Presenter(s) 

Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits. If you have already viewed this content, please click here to login.

Language 

Checkout

Checkout

Do you already own this?

Pricing

Individuals

AIChE Member Credits 0.5
AIChE Pro Members $15.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $25.00
Non-Members $25.00